terlipressin has been researched along with Hyperpotassemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auler Júnior, JO; Carmona, MJ; D'Albuquerque, LA; Holms, CA; Machado, MC; Nani, RS; Rocha Filho, JA; Rocha, JP; Sá Malbouisson, LM | 1 |
| Elisaf, M; Kalambokis, G; Milionis, H; Tsianos, EV | 1 |
2 other study(ies) available for terlipressin and Hyperpotassemia
| Article | Year |
|---|---|
Hyperkalemia accompanies hemorrhagic shock and correlates with mortality.
Topics: Animals; Disease Models, Animal; Fluid Therapy; Heart Arrest; Hemostatics; Hyperkalemia; Lypressin; Male; Resuscitation; Shock, Hemorrhagic; Survival Rate; Swine; Terlipressin | 2009 |
Terlipressin avoids hemodialysis in the treatment of refractory hyperkalemia associated with renal dysfunction in cirrhosis.
Topics: Hepatorenal Syndrome; Humans; Hyperkalemia; Liver Cirrhosis; Lypressin; Male; Middle Aged; Renal Agents; Terlipressin | 2005 |